Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Research Article

Ger. J. Vet. Res.. 2020; 2(1): 1-5

Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus

Ahmed Ali.

Aim: The aim of the current study was to evaluate a trivalent inactivated oil-emulsion vaccine against different clades highly pathogenic avian influenza (AI) viruses including AI-H5N8 and the virulent genotype VII NDV virus (vNDV).
Materials and methods: the vaccine studied herein is composed of AI viruses rg A/Chicken/Egypt/ME1010/2016 (clade, H5N1 rgA/Chicken/Egypt/RG-173CAL/2017 (clade and Newcastle disease virus “NDV” (LaSota NDV/CK/Egypt/11478AF/11); all used at a concentration of 108 EID50/bird and mixed with Montanide-ISA70 oil adjuvant. Two weeks old Specific Pathogen Free (SPF) chickens were immunized subcutaneously with 0.5 ml of the vaccine and hemagglutination inhibition (HI) antibody titers were monitored weekly. Intranasal challenge was conducted 4 weeks post vaccination (PV) using 106EID50/0.1ml of the different virulent AI-H5N1 viruses representing clades 2.2.1,,, and the vNDV.
Results: the vaccine induced HI antibody titers of >6log2 against H5N1 and NDV viruses 2 weeks post vaccination. There was a clinical protection of 100% against all H5N1 viruses and vNDV, whereas 93.3% protection was found against HPAI H5 clade-2.2.1 and HPAI H5 clade- viruses. Challenged birds showed a significant decrease in the titer of virus shedding

Key words: Avian influenza, H5N1, H5N8, Newcastle diseases virus, H5ND, Trivalent vaccine, Egypt

Similar Articles

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

Distribution of antibiotic resistance genes and their association with bacteria and viruses in decentralized sewage treatment facilities.
Zhao J, Li B, Lv P, Hou J, Qiu Y, Huang X
Frontiers of environmental science & engineering. 2022; 16(3): 35

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases.
Maneu V, Lax P, Cuenca N
Neural regeneration research. 2022; 17(1): 103-104

Small scale adeno-associated virus-vector production for preclinical gene delivery based on chloroform precipitation.
Davidsson M, Heuer A
Neural regeneration research. 2022; 17(1): 99-100

Full-text options

Add your Article(s) to Indexes
• citeindex.org

Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.